Coenzyme Q₁₀ and its Relation with Oxidant and Antioxidant System Markers in Patients with End-Stage Renal Disease

References

• Himmelfarb J, Hakim RM. Oxidative stress in uremia. Curr Opin Nephrol Hypertens. 2003;12(6):593–598.
   PubMed Web of Science ®Google Scholar
• Nguyen-Khoa T, Massy ZA, De Bandt JP, Oxidative stress and hemodialysis: Role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant. 2001;16(2):335–340.
   PubMed Web of Science ®Google Scholar
• Danielski M, Ikizler TA, McMonagle E, Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis. 2003;42(2):286–294.
   PubMed Web of Science ®Google Scholar
• Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42(7):1149–1160.
   PubMed Web of Science ®Google Scholar
• Altunoluk B, Soylemez H, Oguz F, Turkmen E, Fadillioglu E. An Angiotensin-converting enzyme inhibitor, zofenopril, prevents renal ischemia/reperfusion injury in rats. Ann Clin Lab Sci. 2006;36(3):326–332.
   PubMedGoogle Scholar
• Karaman A, Turkmen E, Gursul C, Tas E, Fadillioglu E. Prevention of renal ischemia/reperfusion-induced injury in rats by leflunomide. Int J Urol. 2006;13(11):1434–1441.
   PubMed Web of Science ®Google Scholar
• Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of “carbonyl stress” in long-term uremic complications. Kidney Int. 1999;55(2):389–399.
   PubMed Web of Science ®Google Scholar
• Handelman GJ, Walter MF, Adhikarla R, Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int. 2001;59(5):1960–1966.
   PubMed Web of Science ®Google Scholar
• Canaud B, Cristol J, Morena M, Leray-Moragues H, Bosc J, Vaussenat F. Imbalance of oxidants and antioxidants in hemodialysis patients. Blood Purif. 1999;17(2–3):99–106.
   PubMedGoogle Scholar
• Lippa S, Colacicco L, Calla C, Sagliaschi G, Angelitti AG. Coenzyme Q10 levels, plasma lipids and peroxidation extent in renal failure and in hemodialytic patients. Mol Aspects Med. 1994;15 (Suppl. 15):s213–s219.
   Google Scholar
• Lippa S, Colacicco L, Bondanini F, Plasma levels of coenzyme Q(10), vitamin E and lipids in uremic patients on conservative therapy and hemodialysis treatment: Some possible biochemical and clinical implications. Clin Chim Acta. 2000;292(1–2):81–91.
   PubMedGoogle Scholar
• Gazdikova K, Gvozdjakova A, Kucharska J, Spustova V, Braunova Z, Dzurik R. Oxidative stress and plasma concentrations of coenzyme Q10, alpha-tocopherol, and beta-carotene in patients with a mild to moderate decrease of kidney function. Nephron. 2001;88(3):285.
   PubMedGoogle Scholar
• Wanner C, Bahner U, Mattern R, Lang D, Passlick-Deetjen J. Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in hemodialysis patients. Nephrol Dial Transplant. 2004;19(10):2570–2575.
   PubMedGoogle Scholar
• Bentinger M, Tekle M, Dallner G. Coenzyme Q – Biosynthesis and functions. Biochem Biophys Res Commun. 2010;396(1):74–79.
   PubMedGoogle Scholar
• Ernster L. Lipid Peroxidation in Biological Membranes: Mechanism and Implications. Active Oxygens, Lipid Peroxides, and Antioxidents. Boco Raton, FL: CRC Press; 1993.
   Google Scholar
• Guan Z, Soderberg M, Sindelar P, Prusiner SB, Kristensson K, Dallner G. Lipid composition in scrapie-infected mouse brain: Prion infection increases the levels of dolichyl phosphate and ubiquinone. J Neurochem. 1996;66(1):277–285.
   PubMedGoogle Scholar
• Wasowicz W, Neve J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: Importance of extraction pH and influence of sample preservation and storage. Clin Chem. 1993;39(12):2522–2526.
   PubMed Web of Science ®Google Scholar
• Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34(3):497–500.
   PubMed Web of Science ®Google Scholar
• Durak I, Yurtarslanl Z, Canbolat O, Akyol O. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clin Chim Acta. 1993;214(1):103–104.
   PubMed Web of Science ®Google Scholar
• Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol. 2001;54(5):356–361.
   PubMed Web of Science ®Google Scholar
• Guo CH, Wang CL, Chen PC, Yang TC. Linkage of some trace elements, peripheral blood lymphocytes, inflammation, and oxidative stress in patients undergoing either hemodialysis or peritoneal dialysis. Perit Dial Int. 2010; in press.
   Google Scholar
• Ozden M, Maral H, Akaydin D, Cetinalp P, Kalender B. Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients. Clin Biochem. 2002;35(4):269–273.
   PubMed Web of Science ®Google Scholar
• Mircescu G. Oxidative stress: An accomplice to uremic toxicity? J Ren Nutr. 2006;16(3):194–198.
   PubMed Web of Science ®Google Scholar
• Samouilidou EC, Grapsa EJ, Kakavas I, Lagouranis A, Agrogiannis B. Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis. Int Urol Nephrol. 2003;35(3):393–397.
   PubMedGoogle Scholar
• Taskapan MC, Keskin L, Sahin I, Relationship between insulin resistance and malondialdehyde levels in dialysis patients. Ren Fail. 2007;29(5):649–651.
   PubMed Web of Science ®Google Scholar
• Filiopoulos V, Hadjiyannakos D, Takouli L, Metaxaki P, Sideris V, Vlassopoulos D. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis. Int J Artif Organs. 2009;32(12):872–882.
   PubMedGoogle Scholar
• Kayabasi H, Sit D, Atay AE, Yilmaz Z, Kadiroglu AK, Yilmaz ME. Parameters of oxidative stress and echocardiographic indexes in patients on dialysis therapy. Ren Fail. 2010;32(3):328–334.
   PubMed Web of Science ®Google Scholar
• Taskapan MC, Taskapan H, Sahin I, Keskin L, Atmaca H, Ozyalin F. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality. Ren Fail. 2007;29(2):147–154.
   PubMedGoogle Scholar
• Giustarini D, Dalle-Donne I, Tsikas D, Rossi R. Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers. Crit Rev Clin Lab Sci. 2009;46(5–6):241–281.
   PubMed Web of Science ®Google Scholar
• De Vecchi AF, Bamonti F, Novembrino C, Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients. Nephrol Dial Transplant. 2009;24(8):2524–2529.
   PubMedGoogle Scholar